288 related articles for article (PubMed ID: 21803756)
21. Delayed hyperenhancement magnetic resonance imaging is useful in predicting functional recovery of nonischemic left ventricular systolic dysfunction.
Park S; Choi BW; Rim SJ; Shim CY; Ko YG; Kang SM; Ha JW; Jang Y; Chung N; Choe KO; Cho SY
J Card Fail; 2006 Mar; 12(2):93-9. PubMed ID: 16520255
[TBL] [Abstract][Full Text] [Related]
22. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
Moon JC; Mogensen J; Elliott PM; Smith GC; Elkington AG; Prasad SK; Pennell DJ; McKenna WJ
Heart; 2005 Aug; 91(8):1036-40. PubMed ID: 16020591
[TBL] [Abstract][Full Text] [Related]
23. Cardiac magnetic resonance imaging predicts recovery of left ventricular function in acute onset cardiomyopathy.
McLellan AJ; McKenzie SC; Taylor AJ
Heart Lung Circ; 2012 Jan; 21(1):30-5. PubMed ID: 22055931
[TBL] [Abstract][Full Text] [Related]
24. Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy.
Spinner JA; Noel CV; Denfield SW; Krishnamurthy R; Jeewa A; Dreyer WJ; Maskatia SA
Am J Cardiol; 2016 Apr; 117(8):1342-8. PubMed ID: 26892450
[TBL] [Abstract][Full Text] [Related]
25. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy.
Lehrke S; Lossnitzer D; Schöb M; Steen H; Merten C; Kemmling H; Pribe R; Ehlermann P; Zugck C; Korosoglou G; Giannitsis E; Katus HA
Heart; 2011 May; 97(9):727-32. PubMed ID: 21097819
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of discrepant mid-wall late gadolinium enhancement in patients with nonischemic dilated cardiomyopathy.
Ehara S; Matsumoto K; Kitada R; Nishimura S; Shimada K; Yoshiyama M
Heart Vessels; 2018 Dec; 33(12):1482-1489. PubMed ID: 29804280
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.
McCrohon JA; Moon JC; Prasad SK; McKenna WJ; Lorenz CH; Coats AJ; Pennell DJ
Circulation; 2003 Jul; 108(1):54-9. PubMed ID: 12821550
[TBL] [Abstract][Full Text] [Related]
28. Extent of myocardial hyperenhancement on late gadolinium-enhanced cardiovascular magnetic resonance correlates with q waves in hypertrophic cardiomyopathy.
Papavassiliu T; Flüchter S; Haghi D; Süselbeck T; Wolpert C; Dinter D; Kühl H; Borggrefe M
J Cardiovasc Magn Reson; 2007; 9(3):595-603. PubMed ID: 17365241
[TBL] [Abstract][Full Text] [Related]
29. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
[TBL] [Abstract][Full Text] [Related]
30. Functional description of the left ventricle in patients with volume overload, pressure overload, and myocardial disease using cine magnetic resonance imaging.
Wagner S; Auffermann W; Buser P; Semelka RC; Higgins CB
Am J Card Imaging; 1991 Jun; 5(2):87-97. PubMed ID: 10147590
[TBL] [Abstract][Full Text] [Related]
31. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
[TBL] [Abstract][Full Text] [Related]
32. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
[TBL] [Abstract][Full Text] [Related]
33. Late gadolinium-enhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy: a single centre experience.
Soriano CJ; Ridocci F; Estornell J; Pérez-Boscá JL; Pomar F; Trigo A; Planas A; Nadal M; Jacas V; Martinez V; Paya R
Int J Cardiol; 2007 Mar; 116(2):167-73. PubMed ID: 16828180
[TBL] [Abstract][Full Text] [Related]
34. Diffuse late gadolinium enhancement by cardiovascular magnetic resonance predicts significant intraventricular systolic dyssynchrony in patients with non-ischemic dilated cardiomyopathy.
Tigen K; Karaahmet T; Kirma C; Dundar C; Pala S; Isiklar I; Cevik C; Kilicgedik A; Basaran Y
J Am Soc Echocardiogr; 2010 Apr; 23(4):416-22. PubMed ID: 20149594
[TBL] [Abstract][Full Text] [Related]
35. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function.
Watanabe E; Kimura F; Nakajima T; Hiroe M; Kasai Y; Nagata M; Kawana M; Hagiwara N
J Thorac Imaging; 2013 Jan; 28(1):60-6. PubMed ID: 23249970
[TBL] [Abstract][Full Text] [Related]
36. Wall stress determines systolic and diastolic function--Characteristics of heart failure.
Alter P; Koczulla AR; Nell C; Figiel JH; Vogelmeier CF; Rominger MB
Int J Cardiol; 2016 Jan; 202():685-93. PubMed ID: 26454537
[TBL] [Abstract][Full Text] [Related]
37. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome.
Babu-Narayan SV; Kilner PJ; Li W; Moon JC; Goktekin O; Davlouros PA; Khan M; Ho SY; Pennell DJ; Gatzoulis MA
Circulation; 2006 Jan; 113(3):405-13. PubMed ID: 16432072
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging assessment of reverse left ventricular remodeling late after restrictive mitral annuloplasty in early stages of dilated cardiomyopathy.
Westenberg JJ; Braun J; Van de Veire NR; Klautz RJ; Versteegh MI; Roes SD; van der Geest RJ; de Roos A; van der Wall EE; Reiber JH; Bax JJ; Dion RA
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1247-52; discussion 1252-3. PubMed ID: 18544363
[TBL] [Abstract][Full Text] [Related]
39. Depression of heart rate variability in patients with increased ventricular wall stress.
Alter P; Rupp H; Rominger MB; Czerny F; Vollrath A; Klose KJ; Maisch B
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S26-31. PubMed ID: 19250107
[TBL] [Abstract][Full Text] [Related]
40. Late gadolinium enhancement in cardiac transplant patients is associated with adverse ventricular functional parameters and clinical outcomes.
Butler CR; Kumar A; Toma M; Thompson R; Chow K; Isaac D; Kim D; Haykowsky M; Friedrich MG; Paterson I
Can J Cardiol; 2013 Sep; 29(9):1076-83. PubMed ID: 23380296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
